Discontinuation report PMS-LOSARTAN-HCTZ
Report ID | 53201 |
Drug Identification Number | 02392240 |
Brand name | PMS-LOSARTAN-HCTZ |
Common or Proper name | LOSARTAN |
Company Name | PHARMASCIENCE INC |
Market Status | MARKETED |
Active Ingredient(s) | HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM |
Strength(s) | 25MG 100MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 30 |
ATC code | C09DA |
ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Reason for discontinuation | Other (Please describe in comments) |
Anticipated discontinuation date | |
Actual discontinuation date | 2018-06-29 |
Remaining supply date | 2018-06-29 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | PRODUCT IN DEACTIVATION PROCESS |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2018-06-30 | English | Compare |
v2 | 2018-06-29 | French | Compare |
v1 | 2018-06-29 | English | Compare |
Showing 1 to 3 of 3